JPM: PPD C-suite says CROs 'better prepared' as COVID-19 surges, sees pandemic trials a long-term opportunity.

Contract research organization PPD said that while the pandemic is surging again across the world, lessons since March put the industry in a better position to keep trials going, as it says approvals for new vaccines haven't and won't lead to a letup in its COVID-19 trial work. [ABSTRACT FROM AUTHOR]